The low prevalence of ERG gene fusion and PTEN deficiency in Chinese patients with prostate cancer suggests that alternative molecular mechanisms may play important roles in the development of prostate cancer in Asian men. This evidence concerns the gene PTEN and Familial prostate cancer.